Increased AMP deaminase activity decreases ATP content and slows protein degradation in cultured skeletal muscle

PR Davis, SG Miller, NA Verhoeven, JS Morgan… - Metabolism, 2020 - Elsevier
PR Davis, SG Miller, NA Verhoeven, JS Morgan, DA Tulis, CA Witczak, JJ Brault
Metabolism, 2020Elsevier
Background Protein degradation is an energy-dependent process, requiring ATP at multiple
steps. However, reports conflict as to the relationship between intracellular energetics and
the rate of proteasome-mediated protein degradation. Methods To determine whether the
concentration of the adenine nucleotide pool (ATP+ ADP+ AMP) affects protein degradation
in muscle cells, we overexpressed an AMP degrading enzyme, AMP deaminase 3 (AMPD3),
via adenovirus in C2C12 myotubes. Results Overexpression of AMPD3 resulted in a dose …
Background
Protein degradation is an energy-dependent process, requiring ATP at multiple steps. However, reports conflict as to the relationship between intracellular energetics and the rate of proteasome-mediated protein degradation.
Methods
To determine whether the concentration of the adenine nucleotide pool (ATP + ADP + AMP) affects protein degradation in muscle cells, we overexpressed an AMP degrading enzyme, AMP deaminase 3 (AMPD3), via adenovirus in C2C12 myotubes.
Results
Overexpression of AMPD3 resulted in a dose- and time-dependent reduction of total adenine nucleotides (ATP, ADP and AMP) without increasing the ADP/ATP or AMP/ATP ratios. In agreement, the reduction of total adenine nucleotide concentration did not result in increased Thr172 phosphorylation of AMP-activated protein kinase (AMPK), a common indicator of intracellular energetic state. Furthermore, LC3 protein accumulation and ULK1 (Ser 555) phosphorylation were not induced. However, overall protein degradation and ubiquitin-dependent proteolysis were slowed by overexpression of AMPD3, despite unchanged content of several proteasome subunit proteins and proteasome activity in vitro under standard conditions.
Conclusions
Altogether, these findings indicate that a physiologically relevant decrease in ATP content, without a concomitant increase in ADP or AMP, is sufficient to decrease the rate of protein degradation and activity of the ubiquitin-proteasome system in muscle cells. This suggests that adenine nucleotide degrading enzymes, such as AMPD3, may be a viable target to control muscle protein degradation and perhaps muscle mass.
Elsevier